John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia.
The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01795-18. Print 2019 Mar 15.
Live viral vaccines elicit protective, long-lived humoral immunity, but the underlying mechanisms through which this occurs are not fully elucidated. Generation of affinity matured, long-lived protective antibody responses involve close interactions between T follicular helper (T) cells, germinal center (GC) B cells, and T follicular regulatory (T) cells. We postulated that escalating concentrations of antigens from replicating viruses or live vaccines, spread through the hematogenous route, are essential for the induction and maintenance of long-lived protective antibody responses. Using replicating and poorly replicating or nonreplicating orthopox and influenza A viruses, we show that the magnitude of TFH cell, GC B cell, and neutralizing antibody responses is directly related to virus replicative capacity. Further, we have identified that both lymphoid and circulating T:T cell ratios during the peak GC response can be used as an early predictor of protective, long-lived antibody response induction. Finally, administration of poorly or nonreplicating viruses to allow hematogenous spread generates significantly stronger T:T ratios and robust T, GC B cell and neutralizing antibody responses. Neutralizing antibody response is the best-known correlate of long-term protective immunity for most of the currently licensed clinically effective viral vaccines. However, the host immune and viral factors that are critical for the induction of robust and durable antiviral humoral immune responses are not well understood. Our study provides insight into the dynamics of key cellular mediators of germinal center reaction during live virus infections and the influence of viral replicative capacity on the magnitude of antiviral antibody response and effector function. The significance of our study lies in two key findings. First, the systemic spread of even poorly replicating or nonreplicating viruses to mimic the spread of antigens from replicating viruses due to escalating antigen concentration is fundamental to the induction of durable antibody responses. Second, the T:T ratio may be used as an early predictor of protective antiviral humoral immune responses long before memory responses are generated.
活病毒疫苗可引发保护性、长期存在的体液免疫,但这一过程的潜在机制尚未完全阐明。亲和力成熟的、长期保护性抗体反应的产生涉及滤泡辅助 T 细胞(Tfh 细胞)、生发中心(GC)B 细胞和滤泡调节性 T 细胞(Tfr 细胞)之间的密切相互作用。我们假设,从复制病毒或活疫苗中扩散的递增浓度的抗原,通过血源性途径传播,对于诱导和维持长期保护性抗体反应至关重要。使用复制性和低复制性或非复制性正痘病毒和流感 A 病毒,我们表明 Tfh 细胞、GC B 细胞和中和抗体反应的幅度与病毒复制能力直接相关。此外,我们已经确定,在 GC 反应高峰期,淋巴样和循环 T:T 细胞比都可以作为诱导保护性、长期抗体反应的早期预测指标。最后,给予低复制性或非复制性病毒以允许血源性扩散可产生显著更强的 T:T 比以及强大的 T、GC B 细胞和中和抗体反应。中和抗体反应是目前大多数获得许可的临床有效病毒疫苗的长期保护性免疫的最佳已知相关性。然而,对于诱导强大和持久的抗病毒体液免疫反应至关重要的宿主免疫和病毒因素尚未得到很好的理解。我们的研究提供了对活病毒感染期间生发中心反应关键细胞介质动力学的深入了解,以及病毒复制能力对抗病毒抗体反应和效应功能幅度的影响。我们研究的意义在于两个关键发现。首先,即使是低复制性或非复制性病毒的全身扩散,以模拟复制性病毒抗原的扩散,由于抗原浓度的递增,对于诱导持久的抗体反应是至关重要的。其次,T:T 比在产生记忆反应之前很久,就可以作为保护性抗病毒体液免疫反应的早期预测指标。